Skip to main content
SpringerLink
Log in

Thromboprophylaxis in Cancer Surgery

  • Chapter
  • First Online:
Handbook of Thromboprophylaxis

Abstract

The presence of cancer, overt or occult, is thrombogenic to the individual.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Trousseau A. Lectures on Clinical Medicine, delivered at the Hotel-Dieu, Paris. Edited and translated by PV Bazire. London, UK; The New Sydenham Society Publications. 1868;55:281-332.

    Google Scholar 

  2. Aron E. [The 100th anniversary of the death of A. Trousseau.] Presse Med. 1967;75:1429-1430.

    Google Scholar 

  3. Wahrenbrock M, Borsig L, Le D, et al. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest. 2003;112:853-862.

    Google Scholar 

  4. Sack GH Jr, Levin J, Bell WR. Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical pathophysiologic, and therapeutic features. Medicine (Baltimore). 1977;56:1-37.

    Google Scholar 

  5. Bell WR, Starksen NF, Tong S, et al. Trousseau’s syndrome. Devastating coagulopathy in the absence of heparin. Am J Med. 1985;79:423-430.

    Google Scholar 

  6. Holbrook A, Schulman S, Witt DA, et al. Evidence-based management of anticoagulant therapy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e152S-e184S.

    Google Scholar 

  7. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e419S-e494S.

    Google Scholar 

  8. Farge D, Debourdeau P, Beckers M, et al. International clinical guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost. 2013;11: 56-70.

    Google Scholar 

  9. Walker AJ, Card TR, West J, et al. Incidence of venous thromboembolism in patients with cancer – a cohort study using linked United Kingdom databases. Eur J Cancer. 2013;49: 1404-1413.

    Google Scholar 

  10. Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125: 490-493.

    Google Scholar 

  11. Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5:632-634.

    Google Scholar 

  12. Chew HK, Wun T, Harvey DJ, et al. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J Clin Oncol. 2007;25:70-76.

    Google Scholar 

  13. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism in cancer surgery: the @RISTOS project. Ann Surg. 2006;243:89-95.

    Google Scholar 

  14. Baumgartner A, Jacot N, Moser G, et al. Prevention of postoperative deep vein thrombosis by one daily injection of low molecular weight heparin and dihydroergotamine. Vasa. 1989;18:152-156.

    Google Scholar 

  15. Streiff MB, Lau BD. Thromboprophylaxis in nonsurgical patients. Hematology Am Soc Hematol Educ Program. 2012;2012:631-637.

    Google Scholar 

  16. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e227S-e277S.

    Google Scholar 

  17. Goldhaber SZ, Dunn K, Gerhard-Herman M, et al. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest. 2002;122:1933-1937.

    Google Scholar 

  18. Macdonald RL, Amidei C, Baron J, et al. Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol. 2003;59:363-374.

    Google Scholar 

  19. Enoxacan Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. Br J Surg. 1997;84:1099-1103.

    Google Scholar 

  20. Bergqvist D, Agnelli G, Cohen AT, et al; ENOXACAN II investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-980. THROMBOPROPHYLAXI S IN CANCER SURGERY • 53

    Google Scholar 

  21. Akl EA, Labedi N, Terrenato I, et al. Low-molecular-weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Cochrane Database Syst Rev. 2011;11:CD009447.

    Google Scholar 

  22. Kakkar AK, Levine M, Pinedo HM, et al. Venous thrombosis in cancer patients: insights from the frontlinE survey. Oncologist. 2003;8:381-388.

    Google Scholar 

  23. Williams EV, Williams RS, Hughes JL, et al. Prevention of venous thromboembolism in Wales: results of a survey among general surgeons. Postgrad Med J. 2002;78:88-91.

    Google Scholar 

  24. Hopkins L, Carrier M, Plante M, et al. Surgical venous thromboprophylaxis: a cross-sectional survey of Canadian gynaecologic oncologists. J Obstet Gynaecol Can. 2012;34:673-677.

    Google Scholar 

  25. Scottish Intercollegiate Guidelines Network. Prevention and management of venous thromboembolism: a national clinical guideline (SIGN publication no. 122) 2010 (revised 2011). http://www.sign.ac.uk/pdf/sign122.pdf. Accessed January 19, 2016.

  26. Clarke-Pearson DL, Dodge RK, Synan I, et al. Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression. Obstet Gynecol. 2003;101:157-163.

    Google Scholar 

  27. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e195S–e226S.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Conwy and Denbighshire Trust, North Wales, UK

    David Gozzard

  2. Addenbrooke’s Hospital, Cambridge, UK

    David Perry

Authors
  1. David Gozzard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Perry
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Addenbrooke’s Hospital, Cambridge, United Kingdom

    David Perry

  2. Southampton University Hospital, Southampton, United Kingdom

    David Warwick

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Gozzard, D., Perry, D. (2016). Thromboprophylaxis in Cancer Surgery. In: Perry, D., Warwick, D. (eds) Handbook of Thromboprophylaxis. Adis, Cham. https://doi.org/10.1007/978-3-319-21148-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-21148-0_6

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-21147-3

  • Online ISBN: 978-3-319-21148-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation